|
|
Physiological Genomics: From Bench to Bedside
Sponsored by
APS Physiological Genomics Group
Sunday, April 29 — 8:00-10:00 AM
Washington, DC Convention Center — Room
154B
|
| Chaired: |
Susan E. Old, NHLBI, NIH
Melinda R. Dwinell, Med. Col. Wisconsin |
During the past decade, there has been a
great focus on linking biology to the genome. To translate raw genomic
information into valuable information for use in the clinics, we must
identify how genes function in living organisms. Several approaches have
been developed to rapidly integrate complex physiological processes and
interactions with the genome to aid in the understanding of complex
diseases. High-throughput phenotyping and genotyping, bioinformatics
approaches, and publicly available data are allowing scientists to begin
to link gene function with integrative physiology. This symposium will
present several integrative approaches available to translate gene
function from the laboratory to the clinic. This symposium has several
purposes. First, information can be gained from cellular and molecular
studies rapidly but must be expanded to understand the impact on health
and disease in a living system. The first speaker will present recent
studies aimed at understanding the role of hypoxia inducible factor 1
(HIF-1) both at the cellular level as well as in the whole animal and
the resulting clinical implications. The second speaker will describe
how gene expression profiles can be used to dissect genetic and
environmental factors impacting multigenic common diseases. The second
purpose of this symposium is to introduce the audience to available
resources to enable and support researchers interested in expanding
their research to translate genomic information to the entire organism.
The final two speakers will introduce the audience to publicly available
resources to promote and support researchers interested in heart, lung,
blood and sleep disorders. The third speaker will review available
mutant mouse models, the use of phenotype data to identify appropriate
inbred models, and resources for complex trait analysis. The final
speaker will describe how this information can be translated from the
gene or cell level to a living system and used in the clinical setting.
|
8:00 AM |
Physiological responses mediated by
hypoxia-inducible factor 1 and their clinical implications.
Gregg L. Semenza, Johns Hopkins Univ.
|
|
8:30 AM |
Physiogenomic resources for rat models of heart,
lung and blood disorders.
Norman H. Lee, TIGR
|
|
9:00 AM |
New mouse models for heart, lung, blood and sleep
disorders.
Karen L. Svenson, The Jackson Lab.
|
|
9:30 PM |
Translating animal models to the clinical
spectrum.
Anne E. Kwitek, Med. Col. Wisconsin
|
|
|